Multiple System Atrophy clinical trials at UCSF

5 in progress, 1 open to eligible people

Showing trials for

  • Lu AF82422 in Participants With Multiple System Atrophy (MSA)

    open to eligible people ages 40-75

    The main goal of this trial is to evaluate the efficacy and safety of Lu AF82422 for the treatment of participants with Multiple System Atrophy (MSA).

    San Francisco 5391959, California 5332921 and other locations

  • Lu AF82422 in Participants With Multiple System Atrophy

    Sorry, in progress, not accepting new patients

    To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.

    San Francisco 5391959, California 5332921 and other locations

  • Parkinson's And Zoledronic Acid

    Sorry, in progress, not accepting new patients

    This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60 years and older with Parkinson's disease and parkinsonism with at least 2 years of follow-up. A total of 2650 participants will be enrolled and randomized in the United States. Participants, follow-up outcome assessors, and study investigators will be blinded to assigned study treatment. This trial is funded by the National Institute of Aging.

    San Francisco 5391959, California 5332921 and other locations

  • AB-1005 Long-Term Follow-up Study

    Sorry, accepting new patients by invitation only

    This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.

    San Francisco 5391959, California 5332921 and other locations

  • Automated Imaging Differentiation of Parkinsonism

    Sorry, in progress, not accepting new patients

    The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.

    San Francisco 5391959, California 5332921 and other locations

Last updated: